Can EmeraldLED Reshape Your Body With Continued Use?

NCT ID: NCT07282119

Last Updated: 2025-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-29

Study Completion Date

2026-08-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This remotely administered decentralized trial is designed to rigorously explore the efficacy of green light therapy on body composition and overall well-being, under the leadership of Ryan, the CEO of beem® Light Sauna. With over 30 years of experience in the wellness industry, Ryan has observed firsthand the surge in popularity of green light therapy, accompanied by a myriad of claims regarding its benefits. Despite widespread anecdotal evidence suggesting that green light therapy can aid in weight loss and improve mood, there remains a significant gap in scientific research to support these claims conclusively. This study aims to bridge this gap by providing empirical evidence on the effects of green light therapy.

The objective of this study is to empower participants with knowledge about how green light exposure might influence their weight management efforts and overall sense of well-being. By participating in this remote trial, individuals will receive personalized data regarding changes in their body composition and mood, following a structured regimen of green light therapy. This personalized feedback will enable participants to make informed decisions about incorporating green light therapy into their health and wellness routines.

The significance of this study lies in its potential to challenge and possibly redefine existing weight management strategies. By collecting and analyzing data on how green light therapy affects individuals, this study seeks to provide insights that could lead to new, innovative approaches to health and wellness. While acknowledging the limitations of this initial trial, including the necessity for further comprehensive research, the findings could serve as a valuable foundation for future studies and health innovations.

In sum, this decentralized trial represents a critical step towards demystifying the effects of green light therapy on body composition and mood enhancement. Through rigorous scientific investigation, this study aims to validate or debunk the claims surrounding green light therapy, thereby contributing to the broader understanding of its potential benefits and limitations. Participants' involvement is not just a journey towards personal health enlightenment but also a contribution to the global conversation on effective, science-backed wellness strategies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Body Composition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single Arm observational where participants act as their own control
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single arm where participants act as their own control

Single Arm observational where participants act as their own control

Group Type EXPERIMENTAL

EmeraldLED

Intervention Type DEVICE

This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm².

The green light EmeraldLED therapy provided in this study is set at 525 nm.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EmeraldLED

This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm².

The green light EmeraldLED therapy provided in this study is set at 525 nm.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Can read and understand English.
* US resident.
* Willing and able to follow the requirements of the protocol.

Exclusion Criteria

* Individuals with eye conditions
* Individuals not active with EmeraldLED
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Efforia, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Efforia

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Matthew Amsden

Role: CONTACT

Phone: 646-679-2479

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Matthew Amsden

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

44804

Identifier Type: -

Identifier Source: org_study_id